In a study of iodine metabolism in patients with non-toxic nodular goiter (using 127I 
goiter. Werner et al. (1960) have demonstrated triiodothyronine in abnormal concentrations in the plasma and as the major component of a thyroid nodule in a euthyroid person with a non-toxic nodular goiter. Shimaoka (1963) has reported a case of toxic adenoma of the thyroid, in which triiodothyronine was the principal circulating thyroid hormone. Kahn et al. (1962) and Greenspan et al. (1963) Postoperatively, the patient recovered well and has been taking thyroxine 0.2 mg daily to attempt to prevent new goiter formation.
METHODS AND RESULTS
Parts of the thyroid nodule from each of the two patients were obtained at operation, quick frozen in dry ice and removed to the laboratory. The chemical extraction and Chromatographie procedures followed have been described ear¬ lier (Row et al. 1963 ).
In the case of patient R. R., an iodinated compound was detected between the positions of thyroxine and triiodothyronine on the chromatogram. By cochromatography with radioactive tetraiodothyroacetic acid of high specific ac¬ tivity, the compound was identified as the acetic acid analog of thyroxine ( Fig. 1 ). (Fig. 2) . Co-chromatography with pure samples of thyroxine and triiodothyronine showed compound X to be separate from either (Fig. 3) .
Six hundred µ\ of the extract of the nodule were chromatographed as a 12 cm strip and the paper developed in 2BuOH:NH4OH solvent. After locating the position of compound X on the paper by spraying guide strips with eerie sulfate:arsenious acid:methylene blue reagent, the compound was eluted with (Fig. 4) .
Assuming that the compound might be a peptide, an aliquot of the extract was evaporated to dryness, the residue taken in Borate Buffer (0.005 m at pa 8.5) and reacted with purified trypsin for 24 h, at 37°C. The incubation mix¬ ture was re-extracted with n-butanol and re-chromatographed and the chroma¬ togram sprayed for iodocompounds. Compound X again appeared at the original position without having been hydrolysed.
Ultra-violet absorption spectrum
An aliquot of the eluate of compound X was read in a Beckman D. U., spectrophotometer. The maximum absorption was at 270 µ which is similar to the Ultra-violet absorption spectrum of the iodothyronines (Pitt-Rivers 8c Tata 1959).
Infra-red analysis A sample of compound X was subjected to Infra-red analysis using a Perkin-Elmer Infra-red spectrophotometer. The »finger print« region of the infra¬ red spectrum especially between 8 and 9 µ shows a distinct aromatic ether group which is the basic structure of the thyronine molecule (Fig. 5) .
In addition to being eerie sulfate-positive, compound X was also ninhydrinpositive, indicating the presence of amino groups. 
DISCUSSION
In patient R. R., the thyroid nodular tissue was apparently producing iodotyrosines in normal proportions so as to show an MIT:DIT ratio of 0.625 which is close to normal (normal ratio is 0.7). Tetrac was found to be the largest component synthesized by this thyroid tissue. It is well known that the parent compound thyroxine has to undergo oxidative deamination followed by oxidative decarboxylation to form the acetic acid analog (Lissitzky 1959 (Lerman 1960 
